Clinical impact of atrial fibrillation in patients with pulmonary hypertension.

BACKGROUND: Pulmonary hypertension (PH) is associated with progressive impairment of right ventricular function, reduced exercise capacity and a poor prognosis. Little is known about the prevalence, clinical manifestation and impact of atrial fibrillation (AF) on cardiac function in PH. METHODS: In...

Full description

Bibliographic Details
Main Authors: Dennis Rottlaender, Lukas J Motloch, Daniela Schmidt, Sara Reda, Robert Larbig, Martin Wolny, Daniel Dumitrescu, Stephan Rosenkranz, Erland Erdmann, Uta C Hoppe
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3306317?pdf=render
id doaj-5d040aaaa665488a8032b928a78c196f
record_format Article
spelling doaj-5d040aaaa665488a8032b928a78c196f2020-11-25T01:12:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0173e3390210.1371/journal.pone.0033902Clinical impact of atrial fibrillation in patients with pulmonary hypertension.Dennis RottlaenderLukas J MotlochDaniela SchmidtSara RedaRobert LarbigMartin WolnyDaniel DumitrescuStephan RosenkranzErland ErdmannUta C HoppeBACKGROUND: Pulmonary hypertension (PH) is associated with progressive impairment of right ventricular function, reduced exercise capacity and a poor prognosis. Little is known about the prevalence, clinical manifestation and impact of atrial fibrillation (AF) on cardiac function in PH. METHODS: In a four year single-centre retrospective analysis 225 patients with confirmed PH of various origins were enrolled to investigate the prevalence of AF, and to assess the clinical manifestation, 6-minute walk distance, NT-proBNP levels, echocardiographic parameters and hemodynamics obtained by right heart catheterization in PH with AF. RESULTS: AF was prevalent in 31.1%. In patients with PH and AF, parameters of clinical deterioration (NYHA/WHO functional class, 6-minute walk distance, NT-proBNP levels) and renal function were significantly compromised compared to patients with PH and sinus rhythm (SR). In the total PH cohort and in PH not related to left heart disease occurrence of AF was associated with an increase of right atrial pressure (RAP) and right atrial dilatation. While no direct association was found between pulmonary artery pressure (PAP) and AF in these patients, right ventricular function was reduced in AF, indicating more advanced disease. In PH due to left heart failure the prevalence of AF was particularly high (57.7% vs. 23.1% in other forms of PH). In this subgroup, left atrial dilatation, increase of pulmonary capillary wedge pressure, PAP and RAP were more pronounced in AF than in SR, suggesting that more marked backward failure led to AF in this setting. CONCLUSION: PH is associated with increased prevalence of AF. Occurrence of AF in PH indicates clinical deterioration and more advanced disease.http://europepmc.org/articles/PMC3306317?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Dennis Rottlaender
Lukas J Motloch
Daniela Schmidt
Sara Reda
Robert Larbig
Martin Wolny
Daniel Dumitrescu
Stephan Rosenkranz
Erland Erdmann
Uta C Hoppe
spellingShingle Dennis Rottlaender
Lukas J Motloch
Daniela Schmidt
Sara Reda
Robert Larbig
Martin Wolny
Daniel Dumitrescu
Stephan Rosenkranz
Erland Erdmann
Uta C Hoppe
Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
PLoS ONE
author_facet Dennis Rottlaender
Lukas J Motloch
Daniela Schmidt
Sara Reda
Robert Larbig
Martin Wolny
Daniel Dumitrescu
Stephan Rosenkranz
Erland Erdmann
Uta C Hoppe
author_sort Dennis Rottlaender
title Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
title_short Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
title_full Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
title_fullStr Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
title_full_unstemmed Clinical impact of atrial fibrillation in patients with pulmonary hypertension.
title_sort clinical impact of atrial fibrillation in patients with pulmonary hypertension.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description BACKGROUND: Pulmonary hypertension (PH) is associated with progressive impairment of right ventricular function, reduced exercise capacity and a poor prognosis. Little is known about the prevalence, clinical manifestation and impact of atrial fibrillation (AF) on cardiac function in PH. METHODS: In a four year single-centre retrospective analysis 225 patients with confirmed PH of various origins were enrolled to investigate the prevalence of AF, and to assess the clinical manifestation, 6-minute walk distance, NT-proBNP levels, echocardiographic parameters and hemodynamics obtained by right heart catheterization in PH with AF. RESULTS: AF was prevalent in 31.1%. In patients with PH and AF, parameters of clinical deterioration (NYHA/WHO functional class, 6-minute walk distance, NT-proBNP levels) and renal function were significantly compromised compared to patients with PH and sinus rhythm (SR). In the total PH cohort and in PH not related to left heart disease occurrence of AF was associated with an increase of right atrial pressure (RAP) and right atrial dilatation. While no direct association was found between pulmonary artery pressure (PAP) and AF in these patients, right ventricular function was reduced in AF, indicating more advanced disease. In PH due to left heart failure the prevalence of AF was particularly high (57.7% vs. 23.1% in other forms of PH). In this subgroup, left atrial dilatation, increase of pulmonary capillary wedge pressure, PAP and RAP were more pronounced in AF than in SR, suggesting that more marked backward failure led to AF in this setting. CONCLUSION: PH is associated with increased prevalence of AF. Occurrence of AF in PH indicates clinical deterioration and more advanced disease.
url http://europepmc.org/articles/PMC3306317?pdf=render
work_keys_str_mv AT dennisrottlaender clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT lukasjmotloch clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT danielaschmidt clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT sarareda clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT robertlarbig clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT martinwolny clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT danieldumitrescu clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT stephanrosenkranz clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT erlanderdmann clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
AT utachoppe clinicalimpactofatrialfibrillationinpatientswithpulmonaryhypertension
_version_ 1725167500369330176